FUSED HETEROCYCLIC KINASE INHIBITORS

In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.

Saved in:
Bibliographic Details
Main Authors KIM KYOUNG S, VACCARO WAYNE, CHEN ZHONG, HUYNH TRAM N, CHEN XIAO TAO, BORZILLERI ROBERT M, CAI ZHEN WEI
Format Patent
LanguageEnglish
Published 04.04.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
AbstractList In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
Author BORZILLERI ROBERT M
CHEN XIAO TAO
CAI ZHEN WEI
CHEN ZHONG
VACCARO WAYNE
KIM KYOUNG S
HUYNH TRAM N
Author_xml – fullname: KIM KYOUNG S
– fullname: VACCARO WAYNE
– fullname: CHEN ZHONG
– fullname: HUYNH TRAM N
– fullname: CHEN XIAO TAO
– fullname: BORZILLERI ROBERT M
– fullname: CAI ZHEN WEI
BookMark eNrjYmDJy89L5WRQcQsNdnVR8HANcQ3yd4509vF0VvD29HMMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgYG5gYGxuYmJhaOxsSpAgD5mSW2
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20070037448A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20070037448A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20070037448A3
Notes Application Number: KR20067027370
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070404&DB=EPODOC&CC=KR&NR=20070037448A
ParticipantIDs epo_espacenet_KR20070037448A
PublicationCentury 2000
PublicationDate 20070404
PublicationDateYYYYMMDD 2007-04-04
PublicationDate_xml – month: 04
  year: 2007
  text: 20070404
  day: 04
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 2.6694431
Snippet In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title FUSED HETEROCYCLIC KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070404&DB=EPODOC&locale=&CC=KR&NR=20070037448A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp-LHlIKjb0Xsdx-KbGlL61w72k7m00i6FASZw1X89710q-5pbyGBywf55fK75O4AeiJFHNMdW9FshgRFRZ7icF4qJer-wqTzwqDC3jGKzXCiP0-NaQs-Gl-YOk7oTx0cERFVIN6r-rxe_huxvPpv5eqBvWPV51OQu57csGML96QuewPXHydeQmRC3GEqx-m6TcRa0e3-HuzjRdoSePBfB8IvZbmtVIITOBijvEV1Ci2-6MARaXKvdeBwtHnyxuIGfasz6AWTzPek0McraELeyEtEJGTf_cyXojiMBlGepNk53Ad-TkIFu5v9zW42TLfHpl1AG3k_vwSJUlW1KTeZmNOjTR2r1AzTLlWTGZRr-hV0d0m63t18A8drM6X4h9KFdvX1zW9Rv1bsrl6WX1fseUc
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsWPqQVH34rY7z4UWdOW1nXt6DqZTyWdKQgyh6v473vpVt3T3kIClw_yy-V3yd0B9HmKuEK1TEkxCyQoMvIUi7FSKlH3z3X6Ntcot3eMYj2Yqs8zbdaCj8YXpo4T-lMHR0REzRHvVX1eL_-NWG79t3L1ULxj1eeTn9mu2LBjA_ekKrqO7Y0TNyEiIfYwFeN03cZjrajmYA_28ZJtcDx4Lw73S1luKxX_GA7GKG9RnUCLLbrQIU3utS4cjjZP3ljcoG91Cn1_OvFcIfDwCpqQVxKFRED2PZh4QhgHoRNmSTo5g3vfy0ggYXf53-zyYbo9NuUc2sj72QUIlMqySZle8Dk9mtQySkXTzVLWC40yRb2E3i5JV7ub76ATZKMoj8J4eA1Ha5Ml_5PSg3b19c1uUNdWxW29RL8y63w6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FUSED+HETEROCYCLIC+KINASE+INHIBITORS&rft.inventor=KIM+KYOUNG+S&rft.inventor=VACCARO+WAYNE&rft.inventor=CHEN+ZHONG&rft.inventor=HUYNH+TRAM+N&rft.inventor=CHEN+XIAO+TAO&rft.inventor=BORZILLERI+ROBERT+M&rft.inventor=CAI+ZHEN+WEI&rft.date=2007-04-04&rft.externalDBID=A&rft.externalDocID=KR20070037448A